User profiles for Carolina Argondizo Correia
Carolina Argondizo CorreiaDoutoranda, FMUSP Verified email at usp.br Cited by 87 |
[HTML][HTML] Neonatal Immunity to Bordetella pertussis Infection and Current Prevention Strategies
C Argondizo-Correia, AKS Rodrigues… - Journal of immunology …, 2019 - hindawi.com
Bordetella pertussis is the bacterial agent of whooping cough, an infectious disease that is
reemerging despite high vaccine coverage. Newborn children are the most affected, not only …
reemerging despite high vaccine coverage. Newborn children are the most affected, not only …
[HTML][HTML] Humoral and cellular immune responses to CoronaVac up to one year after vaccination
PR Costa, CA Correia, MP Marmorato… - Frontiers in …, 2022 - frontiersin.org
Coronavac is a widely used SARS-CoV-2 inactivated vaccine, but its long-term immune
response assessment is still lacking. We evaluated SARS-CoV-2-specific immune responses, …
response assessment is still lacking. We evaluated SARS-CoV-2-specific immune responses, …
Intravenous glutamine administration modulates TNF-α/IL-10 ratio and attenuates NFkB phosphorylation in a protein malnutrition model
Protein malnutrition (PM) is a major public health problem in developing countries, affecting
the inflammatory response and increasing susceptibility to opportunistic infections. For this …
the inflammatory response and increasing susceptibility to opportunistic infections. For this …
[PDF][PDF] Genotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodies
The resurgence of yellow fever in South America has prompted vaccination against the
etiologic agent, yellow fever virus (YFV). Current vaccines are based on a live-attenuated YF-…
etiologic agent, yellow fever virus (YFV). Current vaccines are based on a live-attenuated YF-…
[HTML][HTML] Humoral and cellular immune responses to CoronaVac assessed up to one year after vaccination
PR Costa, CA Correia, MP Marmorato… - medRxiv, 2022 - ncbi.nlm.nih.gov
Background: The Sinovac SARS-CoV-2 inactivated vaccine (CoronaVac) has been
demonstrated to be safe, well tolerated, and efficacious in preventing mild and severe Covid-19. …
demonstrated to be safe, well tolerated, and efficacious in preventing mild and severe Covid-19. …
Humoral and cellular immune responses to CoronaVac assessed up to one year after vaccination (preprint)
PR Costa, CA Correia, MP Marmorato… - 2022 - pesquisa.bvsalud.org
BackgroundThe Sinovac SARS-CoV-2 inactivated vaccine (CoronaVac) has been
demonstrated to be safe, well tolerated, and efficacious in preventing mild and severe Covid-19. …
demonstrated to be safe, well tolerated, and efficacious in preventing mild and severe Covid-19. …
Gestational pertussis vaccination and the infant's cellular immune response against whole-cell pertussis vaccine in the first year of life
C Argondizo-Correia… - bioRxiv, 2019 - biorxiv.org
Pertussis resurgence worldwide calls for new prevention strategies, as the recently incorporated
vaccine booster dose during pregnancy, whose aim is to protect newborns from infection…
vaccine booster dose during pregnancy, whose aim is to protect newborns from infection…
[HTML][HTML] Experimental design approach in recombinant protein expression: determining medium composition and induction conditions for expression of pneumolysin …
G Marini, MD Luchese, APC Argondizzo… - BMC …, 2014 - Springer
Background Streptococcus pneumoniae (S. pneumoniae) causes several serious diseases
including pneumonia, septicemia and meningitis. The World Health Organization estimates …
including pneumonia, septicemia and meningitis. The World Health Organization estimates …
Levels of Angiopoietin 2 Are Predictive for Mortality in Patients Infected With Yellow Fever Virus
…, MP Marmorato, CA Correia… - The Journal of …, 2023 - academic.oup.com
In 2018 there was a large yellow fever outbreak in São Paulo, Brazil, with a high fatality rate.
Yellow fever virus can cause, among other symptoms, hemorrhage and disseminated …
Yellow fever virus can cause, among other symptoms, hemorrhage and disseminated …
Optimization of medium formulation and seed conditions for expression of mature PsaA (pneumococcal surface adhesin A) in Escherichia coli using a sequential …
…, JFMQ Nicolau, APC Argondizzo… - Journal of Industrial …, 2012 - academic.oup.com
… Ana Paula Corrêa Argondizzo , Ana Paula Corrêa Argondizzo … Ana Carolina Andrade de
Góes (Bio-Manguinhos/Fiocruz) for help in purification analysis, and Prof. Dr. Tito Lívio Moitinho …
Góes (Bio-Manguinhos/Fiocruz) for help in purification analysis, and Prof. Dr. Tito Lívio Moitinho …